Management of Recurrent Hepatocellular Carcinoma After Resection

Overview

Journal Hepatobiliary Surg Nutr

Publisher AME Publishing Company

Date 2020 Dec 10

PMID 33299834

Citations 3

Authors

Hwee Leong Tan

Brian K P Goh

Affiliations

Soon will be listed here.

Citing Articles

Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma.

Liu W, Xie Z, Shen K, Jiang L, Liu C, Ge Y Med Oncol. 2023; 40(9):251.

PMID: 37498394 DOI: 10.1007/s12032-023-02082-x.

Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection.

Adwan H, Hammann L, Vogl T J Clin Med. 2023; 12(7).

PMID: 37048644 PMC: 10094797. DOI: 10.3390/jcm12072560.

Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study.

Wang W, Liu Z, Wang K, Yu H, Cheng Y, Xiang Y Cancer Med. 2023; 12(10):11513-11524.

PMID: 36999793 PMC: 10242311. DOI: 10.1002/cam4.5880.

References

Wang H, Mo D, Zhong J, Ma L, Wu F, Xiang B . Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy. Medicine (Baltimore). 2019; 98(8):e14498. PMC: 6408068. DOI: 10.1097/MD.0000000000014498. View

Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S . Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2014; 261(5):947-55. DOI: 10.1097/SLA.0000000000000710. View

Wen T, Jin C, Facciorusso A, Donadon M, Han H, Mao Y . Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. Hepatobiliary Surg Nutr. 2018; 7(5):353-371. PMC: 6230838. DOI: 10.21037/hbsn.2018.08.01. View

Guo Y, Chua D, Koh Y, Lee S, Cheow P, Kam J . Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma. World J Surg. 2019; 43(10):2587-2594. DOI: 10.1007/s00268-019-05051-6. View

Fukushima K, Fukumoto T, Kuramitsu K, Kido M, Takebe A, Tanaka M . Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg. 2013; 18(4):729-36. DOI: 10.1007/s11605-013-2423-y. View

Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J . Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol. 2010; 8:55. PMC: 2904292. DOI: 10.1186/1477-7819-8-55. View

Yang S, Luo Y, Chen M, Zhou Y, Lu F, Deng D . A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy. HPB (Oxford). 2017; 19(10):835-842. DOI: 10.1016/j.hpb.2017.06.002. View

Goh B, Syn N, Teo J, Guo Y, Lee S, Cheow P . Perioperative Outcomes of Laparoscopic Repeat Liver Resection for Recurrent HCC: Comparison with Open Repeat Liver Resection for Recurrent HCC and Laparoscopic Resection for Primary HCC. World J Surg. 2018; 43(3):878-885. DOI: 10.1007/s00268-018-4828-y. View

Hao S, Fan P, Chen S, Tu C, Wan C . Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma. J Gastrointest Surg. 2016; 21(2):312-320. DOI: 10.1007/s11605-016-3311-z. View

10.

Huang Z, Liang B, Xiong M, Zhan D, Wei S, Wang G . Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol. 2012; 19(8):2515-25. DOI: 10.1245/s10434-012-2269-7. View

11.

Liu K, Chen Y, Wu X, Huang Z, Lin Z, Jiang J . Laparoscopic liver re-resection is feasible for patients with posthepatectomy hepatocellular carcinoma recurrence: a propensity score matching study. Surg Endosc. 2017; 31(11):4790-4798. DOI: 10.1007/s00464-017-5556-3. View

12.

Lim C, Shinkawa H, Hasegawa K, Bhangui P, Salloum C, Gomez Gavara C . Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis. Liver Transpl. 2017; 23(12):1553-1563. DOI: 10.1002/lt.24952. View

13.

Song P, Tobe R, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y . The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Liver Int. 2012; 32(7):1053-63. DOI: 10.1111/j.1478-3231.2012.02792.x. View

14.

Hu Z, Wang W, Li Z, Ye S, Zheng S . Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis. Liver Transpl. 2012; 18(11):1316-23. DOI: 10.1002/lt.23521. View

15.

Marrero J, Kulik L, Sirlin C, Zhu A, Finn R, Abecassis M . Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018; 68(2):723-750. DOI: 10.1002/hep.29913. View

16.

Fretland A, Dagenborg V, Bjornelv G, Kazaryan A, Kristiansen R, Fagerland M . Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial. Ann Surg. 2017; 267(2):199-207. DOI: 10.1097/SLA.0000000000002353. View

17.

Wang D, Liu L, Qi X, Su C, Chen X, Liu X . Hepatic Re-resection Versus Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma after Initial Resection: a Systematic Review and Meta-analysis. Asian Pac J Cancer Prev. 2015; 16(13):5573-8. DOI: 10.7314/apjcp.2015.16.13.5573. View

18.

Rahbari N, Garden O, Padbury R, Brooke-Smith M, Crawford M, Adam R . Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011; 149(5):713-24. DOI: 10.1016/j.surg.2010.10.001. View

19.

Song Q, Ren W, Fan L, Zhao M, Mao L, Jiang S . Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection. Dig Dis Sci. 2019; 65(4):1266-1275. DOI: 10.1007/s10620-019-05733-0. View

20.

Guo Y, Tan E, Krishnamoorthy T, Tan C, Tan B, Tan T . Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant. Ann Hepatobiliary Pancreat Surg. 2019; 23(1):1-7. PMC: 6405363. DOI: 10.14701/ahbps.2019.23.1.1. View